← Back to Search

Peer Recovery Support for Substance Use Disorders (P2P Trial)

N/A
Waitlist Available
Led By Kristyn Zajac, PhD
Research Sponsored by UConn Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age between 18-25
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days from initiation of treatment
Awards & highlights

Summary

This trialwill study how to help 18-25 year olds stay in substance use treatment and reduce the risk of opiate addiction. It'll also look at risk factors & finances.

Who is the study for?
This trial is for young adults aged 18-25 who are starting outpatient treatment for substance use issues. It's designed to help them stick with their treatment program and not drop out early.Check my eligibility
What is being tested?
The study tests a new support service delivered by peers who have recovered from addiction themselves. This service aims to improve how well young adults follow through with their substance use disorder treatments.See study design
What are the potential side effects?
Since the intervention involves peer-delivered support rather than medication, there may be no direct medical side effects. However, participants might experience emotional or psychological impacts as they engage in the recovery process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 25 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days from initiation of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days from initiation of treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of missed sessions and no show sessions
Number of patients who dropout from substance use services

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Peer Recovery Support - Delivered Dropout Prevention + Usual ServicesExperimental Treatment1 Intervention
clinics will continue to deliver their normal outpatient services plus the peer recovery support-delivered dropout prevention enhancement
Group II: Usual ServicesActive Control1 Intervention
clinics will continue to deliver their normal outpatient services

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Substance Use Disorder (SUD) such as motivational interviewing, cognitive-behavioral therapy (CBT), and 12-step facilitation work by providing encouragement, guidance, and shared experiences to improve treatment adherence and reduce dropout rates. Motivational interviewing helps patients resolve ambivalence about their substance use and enhances their motivation to change. CBT focuses on modifying biased cognitions and behaviors that contribute to substance use, while 12-step facilitation encourages participation in mutual help groups like Alcoholics Anonymous, fostering a supportive community. These mechanisms are crucial for SUD patients as they address both the psychological and social aspects of addiction, promoting sustained recovery and reducing the likelihood of relapse.
Benefits of peer support groups in the treatment of addiction.Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients.On treatment mechanisms--what can we learn from the COMBINE study?

Find a Location

Who is running the clinical trial?

UConn HealthLead Sponsor
211 Previous Clinical Trials
58,871 Total Patients Enrolled
University of Texas at AustinOTHER
359 Previous Clinical Trials
80,003 Total Patients Enrolled
Oregon Social Learning CenterOTHER
35 Previous Clinical Trials
9,025 Total Patients Enrolled

Media Library

Peer Recovery Support-Delivered Dropout Prevention enhancement Clinical Trial Eligibility Overview. Trial Name: NCT05374395 — N/A
Substance Use Disorder Research Study Groups: Usual Services, Peer Recovery Support - Delivered Dropout Prevention + Usual Services
Substance Use Disorder Clinical Trial 2023: Peer Recovery Support-Delivered Dropout Prevention enhancement Highlights & Side Effects. Trial Name: NCT05374395 — N/A
Peer Recovery Support-Delivered Dropout Prevention enhancement 2023 Treatment Timeline for Medical Study. Trial Name: NCT05374395 — N/A
~907 spots leftby Oct 2025